Post-marketing, Observational Study to Confirm the Safety and Efficacy of MARVELON (Study P06083)
The purpose of this study is to evaluate the efficacy and safety of Marvelon® in the prevention of pregnancy.
Post-marketing surveys are not considered applicable clinical trials and thus the results of this survey will not be posted at its conclusion. The results will be submitted to public health officials as required by applicable national and international laws.
|Study Design:||Observational Model: Ecologic or Community
Time Perspective: Prospective
|Official Title:||Drug Use Investigation of MARVELON|
- Number of participants who did not get pregnant during the study. [ Time Frame: End of every 12 menstrual cycles up to 36 or at the termination of drug administration. ] [ Designated as safety issue: No ]
|Study Start Date:||May 2005|
|Study Completion Date:||March 2009|
|Primary Completion Date:||March 2009 (Final data collection date for primary outcome measure)|
Single arm study. All participants receive Marvelon® according to the approved dosage and administration method.
Drug: Ethinylestradiol + Desogestrel
All participants receive Marvelon® according to the approved dosage and administration method.
Women with willingness to prevent pregnancy, who do not meet any of the contraindications, and who will take Marvelon® in compliance with the approved dosage and administration method will be enrolled.
No Contacts or Locations Provided